In the same real-world evaluation of tirzepatide and semaglutide, which is true regarding the weight loss findings? A. Semaglutide participants lost more weight on average than tirzepatide. B. Both semaglutide and tirzepatide participants lost on average similar weight. C. Participants with diabetes lost more weight than those without diabetes on either therapy. D. The majority of patients discontinued therapy during the study.